• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 患者的毛霉菌病及其并发症表现:病例系列研究。

Manifestations of Mucormycosis and Its Complications in COVID-19 Patients: A Case Series Study.

机构信息

Departmentof Otorhinolaryngology, Loghman Hakim Educational Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

出版信息

Ear Nose Throat J. 2024 Jun;103(1_suppl):145S-152S. doi: 10.1177/01455613221143859. Epub 2022 Dec 29.

DOI:10.1177/01455613221143859
PMID:36583239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9805989/
Abstract

OBJECTIVE

Mucormycosis is an opportunistic fungal disease that affects immunocompromised patients. With the advent of SARS-CoV-2, this opportunistic disease has increased.

METHODS

A case series of 47 patients with COVID-19 associated mucormycosis have been analyzed. Demographic information, signs, symptoms, laboratory investigations, imaging studies, and their association with ICU admission and 30-day mortality were assessed.

RESULTS

Total number of 47 consecutive rhino-orbital cerebral mucormycosis (ROCM) cases were analyzed. Periorbital swelling was the most common sign among patients. Majority of cases had diabetes. All patients received liposomal Amphotericin B. Debridement was performed for all cases.

CONCLUSIONS

SARS-CoV-2 increases the susceptibility to mucormycosis infection in various ways. Uncontrolled level of HbA1c in all patients, even non-diabetic individuals, indicates hyperglycemia over the past three months. Diabetes, orbital exenteration, ptosis, periorbital swelling, DKA, LOC, brain involvement, and mechanical ventilation all correlated with a higher rate of ICU admission and 30-day mortality. In addition, a higher white blood cell count is related to the higher probability of ICU admission. While considering all of the inflammatory laboratory data and HbA1c could help predict 30-day mortality.

摘要

目的

毛霉菌病是一种机会性真菌感染疾病,影响免疫功能低下的患者。随着 SARS-CoV-2 的出现,这种机会性疾病有所增加。

方法

分析了 47 例 COVID-19 相关毛霉菌病患者的病例系列。评估了人口统计学信息、体征、症状、实验室检查、影像学研究及其与 ICU 入院和 30 天死亡率的关系。

结果

共分析了 47 例连续的鼻眶脑毛霉菌病(ROCM)病例。眶周肿胀是患者最常见的体征。大多数病例有糖尿病。所有患者均接受脂质体两性霉素 B 治疗。所有病例均行清创术。

结论

SARS-CoV-2 通过多种方式增加了对毛霉菌感染的易感性。所有患者(甚至非糖尿病患者)的 HbA1c 均未得到控制,表明过去三个月存在高血糖。糖尿病、眼眶内容物剜除术、上睑下垂、眶周肿胀、DKA、LOC、脑部受累和机械通气均与 ICU 入院和 30 天死亡率的增高相关。此外,白细胞计数较高与 ICU 入院的可能性较高相关。考虑所有炎症性实验室数据和 HbA1c 有助于预测 30 天死亡率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4096/9805989/f81d5e2d15b9/10.1177_01455613221143859-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4096/9805989/484f09f36fd8/10.1177_01455613221143859-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4096/9805989/f81d5e2d15b9/10.1177_01455613221143859-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4096/9805989/484f09f36fd8/10.1177_01455613221143859-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4096/9805989/f81d5e2d15b9/10.1177_01455613221143859-fig2.jpg

相似文献

1
Manifestations of Mucormycosis and Its Complications in COVID-19 Patients: A Case Series Study.COVID-19 患者的毛霉菌病及其并发症表现:病例系列研究。
Ear Nose Throat J. 2024 Jun;103(1_suppl):145S-152S. doi: 10.1177/01455613221143859. Epub 2022 Dec 29.
2
Is mucormycosis the end? A comprehensive management of orbit in COVID associated rhino-orbital-cerebral mucormycosis: preserving the salvageable.是否意味着毛霉菌病的终结?COVID 相关的鼻-眶-脑毛霉菌病的全面管理:保留可挽救的。
Eur Arch Otorhinolaryngol. 2023 Feb;280(2):819-827. doi: 10.1007/s00405-022-07620-3. Epub 2022 Sep 2.
3
COVID-19 associated rhino-orbital-cerebral mucormycosis-an institutional series.COVID-19 相关的鼻眶脑毛霉菌病——一项机构系列研究。
Ear Nose Throat J. 2024 Jun;103(1_suppl):134S-144S. doi: 10.1177/01455613221077882. Epub 2022 Feb 18.
4
COVID-19-associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis.COVID-19 相关的鼻眶脑毛霉菌病:系统评价、荟萃分析和荟萃回归分析。
Indian J Pharmacol. 2021 Nov-Dec;53(6):499-510. doi: 10.4103/ijp.ijp_839_21.
5
Increased incidence of rhino-orbital mucormycosis in an educational therapeutic hospital during the COVID-19 pandemic in western Iran: An observational study.在伊朗西部 COVID-19 大流行期间,一所教学治疗医院中鼻-眶-脑毛霉菌病发病率的增加:一项观察性研究。
Mycoses. 2021 Nov;64(11):1366-1377. doi: 10.1111/myc.13351. Epub 2021 Jul 31.
6
Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1.印度 2826 例 COVID-19 相关的鼻-眶-脑毛霉菌病的流行病学、临床特征、治疗和结局 - 合作 OPAI-IJO 新冠病毒相关毛霉菌病研究(COSMIC),报告 1。
Indian J Ophthalmol. 2021 Jul;69(7):1670-1692. doi: 10.4103/ijo.IJO_1565_21.
7
Clinical Presentations, Management and Outcomes of Rhino-Orbital-Cerebral Mucormycosis (ROCM) Following COVID-19: A Multi-Centric Study.COVID-19 后鼻眶脑毛霉菌病(ROCM)的临床特征、治疗及结局:一项多中心研究。
Ophthalmic Plast Reconstr Surg. 2021;37(5):488-495. doi: 10.1097/IOP.0000000000002030.
8
First report of COVID-19-associated rhino-orbito-cerebral mucormycosis in pediatric patients with type 1 diabetes mellitus.首例 COVID-19 相关的 1 型糖尿病儿童患者发生鼻-眶-脑毛霉菌病。
J Mycol Med. 2021 Dec;31(4):101203. doi: 10.1016/j.mycmed.2021.101203. Epub 2021 Sep 4.
9
Rhino-orbito-cerebral mucormycosis: report of two cases and review of the literature.鼻眶脑毛霉菌病:两例报告及文献复习
Dentomaxillofac Radiol. 2008 Mar;37(3):161-6. doi: 10.1259/dmfr/14698002.
10
Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients.COVID-19 相关的非糖尿病、免疫功能正常患者的鼻眶脑毛霉菌病。
Orbit. 2021 Dec;40(6):499-504. doi: 10.1080/01676830.2021.1960382. Epub 2021 Aug 1.